IP Library Granted Patent US 7,312,235
Granted Patent B2
US 7,312,235 · App. 10/115,135 · Granted Dec 25, 2007

Benzamide inhibitors of factor Xa

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,312,235
App. No.
10/115,135
Granted
Dec 25, 2007
Kind
B2
Abstract

Novel benzamide compounds, their salts and compositions related thereto having activity against mammalian Factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.

Claims (191)

1. A compound of formula Ia:

wherein:

Ar1 is independently selected from the group consisting of:

each R is independently selected from the group consisting of Cl, OMe, NHMe, —NMe 2 , —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 , —SMe, —SO 2 Me,

L1 is a direct link, —CONH, —CH 2 NH, or —NHCO—;

L2 is —CONH, or —NHCO;

Ar3 is

Ar2 is independently selected from the group consisting of:

Ar2 may be optionally substituted with 0-3 R 1d group; each R 1d is independently selected from the group consisting of:

H, —Me, —F, —Cl, —Br, I, —CH 3 , —CF 3 , —CN, —CO 2 H, —CO 2 Me, —CO 2 Et, —CONH 2 , —CONHMe, —CONMe 2 , —CH 2 NMe 2 , —COMe, —CH 2 COOH,

—OCH 3 , —OCF 3 , —OCH 2 F, —OCHF 2 , —OCH 2 CF 3 , —OCF 2 CF 3 , —OCH 2 CO 2 H, —OCH 2 CO 2 Me, —OCH 2 CO 2 Et, —OCH 2 CONH 2 , —OCH 2 CONMe 2 , —OCH 2 CONHMe, —OCH 2 CH 2 OMe, —OCH 2 CH 2 NHMe, —OCH 2 CH 2 NMe 2 ,

—SCH 3 , —SO 2 NH 2 , —SO 2 CH 3 , —SO 2 NMe 2 , —NMe 2 , —NHCH 2 NMe 2 , —N(CH 2 CH 2 OH) 2 , —N(CH 2 CH 2 OMe) 2 , —NHCH 2 CO 2 H, —NHCH 2 CO 2 Et, —NHCH 2 CO 2 Et, —NHCH 2 CONH 2 , —NHCH 2 CONMe 2 , —N(Me)CH 2 CH 2 NMe 2 , —N(Me)CH 2 CH 2 OMe, —NHCH 2 CH 2 OMe, —NHCH 2 CH 2 OMe;

A is independently selected from the group consisting of:

and all pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrugs derivatives thereof.

2. The compound according to claim 1 wherein L1 or L2 is —CONH.

3. The compound according to claim 1 , wherein Ar1 is independently selected from the group consisting of:

each R is independently selected from the group consisting of Cl, OMe, NHMe, —NMe 2 , —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 , —SMe, —SO 2 Me,

Ar3 is

Ar2 may be optionally substituted with 0-3 R 1d groups;

each R 1d is independently selected from the group consisting of:

H, —Me, —Cl, —Br, —OCH 3 , —OCF 3 , —OCH 2 F, —OCHF 2 , —OCH 2 CF 3 , —OCF 2 CF 3 , —OCH 2 CO 2 H, —OCH 2 CO 2 Me, —OCH 2 CO 2 Et, —OCH 2 CONH 2 , —OCH 2 CONMe 2 , —OCH 2 CONHMe, —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 ,

—F, —I, —CH 2 —CF 3 —CN, —CO 2 H, —CO 2 Me, —CO 2 Et, —CONH 2 , —CONHMe, —CONMe 2 , —CH 2 NH 2 , —CH 2 NHMe, —CH 2 NMe 2 , —COMe, —CH 2 COOH, —CH 2 COOEt,

—SCH 3 , —SO 2 NH 2 , —SO 2 CH 3 , —SO 2 NMe 2 ,

—NMe 2 , —NHCH 2 NMe 2 , —N(CH 2 CH 2 OH) 2 , —N(CH 2 CH 2 OMe) 2 , —NHCH 2 CO 2 H, —NHCH 2 CO 2 Et, —NHCH 2 CO 2 Et, —NHCH 2 CONH 2 , —NHCH 2 CONMe 2 , —N(Me)CH 2 CH 2 NMe 2 , —N(Me)CH 2 CH 2 OMe, —NHCH 2 CH 2 OMe, —NHCH 2 CH 2 OMe,

A is independently selected from the group consisting of:

and all pharmaceutically acceptable isomers, salts, hydrates, solvates, and prodrug derivatives therof.

4. The compound according to claim 1 having the formula:

wherein:

Ar1 is independently selected from the group consisting of:

each R is independently selected from the group consisting of Me, OMe, NH 2 , NHMe, —NME 2 , —SMe, —SO 2 Me, —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 ,

Ar3 is

each R 1d1 is independently selected from the group consisting of:

H, —Me, —Cl, —OCH 3 , —OCF 3 , —OCH 2 F, —OCHF 2 , —OCH 2 CF 3 , —OCF 2 CF 3 , —OCH 2 CO 2 H, —OCH 2 CO 2 Me, —OCH 2 CO 2 Et, —OCH 2 CONH 2 , —OCH 2 CONMe 2 , —OCH 2 CONHMe, —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 ,

—NMe 2 , —NHCH 2 NMe 2 , —N(CH 2 CH 2 OMe) 2 , —NHCH 2 CO 2 H, —NHCH 2 CO 2 Et, —NHCH 2 CO 2 Et, —NHCH 2 CONH 2 , —NHCH 2 CONMe 2 , —N(Me)CH 2 CH 2 NMe 2 , —N(Me)CH 2 CH 2 OMe, —NHCH 2 CH 2 OMe,

each R 1d2 and R 1d3 is independently selected from the group consisting of:

H, —Me, —F, —Cl, —Br, —I, —CH 2 —CF 3 , —CN, —CO 2 H, —CO 2 Me, —CO 2 Et, —CONH 2 , —CONHMe, —CONMe 2 , —CH 2 NH 2 , —CH 2 NHMe, —CH 2 NMe 2 , —COMe, —CH 2 COOH, —CH 2 COOEt,

—OCH 3 , —OCF 3 , —OCH 2 F, —OCHF 2 , —OCH 2 CF 3 , —OCF 2 CF 3 , —OCH 2 CO 2 H, —OCH 2 CO 2 Me, —OCH 2 CO 2 Et, —OCH 2 CONH 2 , —OCH 2 CONMe 2 , —OCH 2 CONHMe, —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 ,

—SCH 3 , —SO 2 NH 2 , —SO 2 CH 3 , —SO 2 NMe 2 , —SCH 2 CH 2 OMe, —SO 2 CH 2 CH 2 OMe, —SO 2 NH 2 , —SO 2 CH 3 , —SO 2 NMe 2 , —SO 2 CH 2 CH 2 NMe, —NMe 2 , —NHCH 2 CH 2 NMe 2 , —N(CH 2 CH 2 OH) 2 , —N(CH 2 CH 2 OMe) 2 , —NHCH 2 CO 2 H, —NHCH 2 CO 2 Et, —NHCH 2 CO 2 Et, —NHCH 2 CONH 2 , —NHCH 2 CONMe 2 , —N(Me)CH 2 CH 2 NMe 2 , —N(Me)CH 2 CH 2 OMe;

and A is independently selected from the group consisting of:

and all pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives thereof.

5. The compound according to claim 1 , having the formula:

wherein Ar1 is independently selected from the group consisting of:

each R is independently selected from the group consisting of Cl, OMe, NHMe, —NMe 2 , —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 ,

Ar3is

each R 1d1 is independently selected from the group consisting of H, —Me, —Cl, —OCH 3 , —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 , —NMe 2 , —N(Me)CH 2 CH 2 NMe 2 , —N(Me)CH 2 CH 2 OMe,

each R 1d1 and R 1d3 is independently selected from the group consisting of:

H, —C≡CH, —Me, —F, —Cl, —Br, —CF 3 , —CN, —CO 2 H, —CO 2 Me, —CO 2 Et, —CONH 2 , —CH 2 NMe 2 , —COMe, —NMe 2 , —SMe, —SCH 2 CH 2 OMe, —SO 2 CH 2 CH 2 OMe, —SCH 3 , —SO 2 NH 2 , —SO 2 CH 3 , —SO 2 NMe 2 , and —SO 2 CH 2 CH 2 NMe 2 ;

and A is independently selected from the group consisting of:

and pharmaceutically acceptable isomers salts, hydrates, solvates and prodrug derivatives thereof.

6. The compound according to claim 1 having the formula:

wherein:

Ar1 is independently selected from the group consisting of:

each R is independently selected from the group consisting of Cl, OMe, NHMe, —NMe 2 , —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 ,

Ar3 is

7. The compound according to claim 1 having the formula:

wherein:

Ar1 is independently selected from the group consisting of:

each R is independently selected from the group consisting of —Cl, —OMe, —NHMe, —NMe 2 , —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 ,

and A is independently selected from the group consisting of:

and all pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives thereof.

8. The compound according to claim 1 having the formula:

wherein:

Ar1 is independently

each R is independently selected from the group consisting of —Cl, —OMe, —NMe 2 , —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 ,

A is independently selected from the group consisting of:

and all pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives thereof.

9. The compound according to claim 1 having the formula

wherein

Ar1 is independently selected from the group consisting of:

each R is independently selected from the group consisting of —Cl, —OMe, —NHMe, —NMe 2 , —OCH 2 CH 2 OMe, and —OCH 2 CH 2 NMe 2 ;

A is independently selected from the group consisting of:

10. The compound according to claim 1 having the formula

wherein

each R is independently selected from the group consisting of —H, —F, —Cl, —OMe, —NMe 2 , —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 ,

11. The compound according to claim 1 having the formula:

wherein

each R 1d2 is independently selected from the group consisting of:

H, —C≡CH, —C—≡—CH, —Me, —F, —Cl, —Br, —CF 3 , —CN, —CO 2 H, —CO 2 Me, —CO 2 Et, —CONH 2 , —CH 2 NMe 2 , —COMe, —NMe 2 , —SMe, —SCH 2 CH 2 OMe, —SO 2 CH 2 CH 2 OMe, —SCH 3 , —SO 2 NH 2 , —SO 2 CH 3 , —SO 2 NMe 2 , and —SO 2 CH 2 CH 2 NMe 2 .

12. The compound according to claim 1 having the formula:

wherein:

each R 1d1 is independently selected from the group consisting of H, OMe, and NMe 2 :

each R 1d3 is independently selected from the group consisting of Cl, Br, —C≡CH, and —C—≡—CH;

and all pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives thereof.

13. The compound according to claim 1 having the formula:

wherein:

each R 1d3 is independently selected from the group consisting of Cl, Br, —C≡CH, and C—≡—CH;

and all pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives thereof.

14. The compound according to claim 1 having the formula:

wherein:

each R 1d3 is independently selected from the group consisting of Cl, Br, —C≡CH, and C—≡—CH;

and all pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives thereof.

15. The compound according to claim 1 having the formula:

wherein:

each R is independently selected from the group consisting of —H, —F, —Cl, —OMe, —NMe 2 , —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 ,

each R 1d3 is independently selected from the group consisting of Cl, Br, —C≡CH, and C—≡—CH.

16. The compound according to claim 1 having the formula:

wherein:

each R is independently selected from the group consisting of —H, —F, —Cl, —OMe, —NMe 2 , —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 ,

each R 1d2 is independently selected from the group consisting of Cl, Br, —C≡CH, and C—≡—CH;

and all pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives thereof.

17. The compound according to claim 1 having the formula:

wherein:

each R is independently selected from the group consisting of —H, —F, —Cl, —OMe, —NMe 2 , —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 ,

each R 1d3 is independently selected from the group consisting of Cl, Br, —C≡CH, and C—≡—CH.

18. The compound according to claim 1 having the formula:

wherein:

each R is independently selected from the group consisting of —H, —F, —Cl, —OMe, —SMe, —NMe 2 , —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 ,

each R 1d3 is independently selected from the group consisting of Cl, Br, —C≡CH, and C—≡—CH.

19. The compound according to claim 1 having the formula:

wherein:

each R is independently selected from the group consisting of Cl, OMe, —NMe 2 , —OCH 2 CH 2 OMe, —OCH 2 CH 2 NMe 2 ,

each R 1d3 is independently selected from the group consisting of Cl, Br, —C≡CH, and C—≡—CH.

20. The compound according to claim 1 selected from the group consisting of:

{4-[(dimethylamino)iminomethyl]phenyl}-N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}[4-( 1-methyl(2-imidazolin-2-yl))phenyl]-carboxamide;

N-(2-[N-(5-ethynyl(2-pyridyl))carbamoyl]-4-chlorophenyl}[4-(iminopyrrolidinylmethyl)phenyl]carboxamide;

N-{2-[N-(5-ethynyl(2-pyridyl))carbamoyl]-4-chlorophenyl}[4-(piperidyliminomethyl)phenyl]carboxamide;

ethyl 1-{[4-(N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carbamoyl)phenyl]iminomethyl}-piperidine-4-carboxylate;

1-{[4-(N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carbamoyl)phenyl]iminomethyl}-piperidine-4-carboxamide;

{4-[(N-ethylmethylamino)iminomethyl]phenyl}-N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

{4-[(N-methylpropylamino)iminomethyl]phenyl}-N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

{4-[Azetidinylazetidinylidenemethy]phenyl}-N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

[4-({[2-(dimethylamino)ethyl]methylamino}iminomethyl)phenyl]-N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carboxamide;

{4-[(N-methyl-2-propynylamino)iminomethyl]phenyl}-N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

{4-[(N-methyl-2-cyanoethylamino)iminomethyl]phenyl}-N-(4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

{4-[(dimethylamino)iminomethyl]-2-fluorophenyl}-N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

N-{2-[N-(5-ethynyl(2-pyridyl))carbamoyl]-4-chlorophenyl}[4-(iminopyrrolidinylmethyl)-2-fluorophenyl]carboxamide;

ethyl 1-{[4-(N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carbamoyl)-3-fluorophenyl]iminomethyl}piperidine-4-carboxylate;

1-{[4-(N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carbamoyl)-3-fluorophenyl]iminomethyl}piperidine-4-carboxamide;

N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}[4-(1-methyl(2-imidazolin-2-yl))-2-fluorophenyl]-carboxamide;

{4-[(N-methyl(phenylmethyl)amino)iminomethyl]-2-fluorophenyl}-N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

{4-[(N-(2-methoxyethyl)methylamino)iminomethyl]-2-fluorophenyl}-N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

{4-[(N-methyl(furanylmethyl)amino)iminomethyl]-2-fluorophenyl}-N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

N-(4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}[4-(1-(2-hydroxyethyl)(2-imidazolin-2-yl))-2-fluorophenyl]-carboxamide;

N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}[4-(1-propyl(2-imidazolin-2-yl))-2-fluorophenyl]-carboxamide;

{4-[(N-(2-[1,3]Dioxolan-2-yl-ethyl)methylamino)iminomethyl]-2-fluorophenyl}-N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

1-{[4-(N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carbamoyl)-3-fluorophenyl]iminomethyl}-4-phenylpiperazine;

{4-[(dimethylamino)iminomethyl]phenyl}-N-{4-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

{4-[(dimethylamino)iminomethyl]phenyl}-N-{4-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

N-{2-[N-(5-ethynyl(2-pyridyl))carbamoyl]-4-methoxyphenyl}[4-(iminopyrrolidinylmethyl)phenyl]carboxamide;

N-{2-[N-(5-ethynyl(2-pyridyl))carbamoyl]-4-methoxyphenyl}[4-(iminopiperidylmethyl)phenyl]carboxamide;

ethyl 1-{[4-(N-{4-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carbamoyl)phenyl]iminomethyl}-piperidine-4-carboxylate;

(4-[(dimethylamino)iminomethyl]-2-fluorophenyl}-N-{4-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

N-{4-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}[4-(1-methyl(2-imidazolin-2-yl))-2-fluorophenyl]-carboxamide;

N-{2-[N-(5-ethynyl(2-pyridyl))carbamoyl]-4-methoxyphenyl}[4-(iminopyrrolidinylmethyl)-2-fluorophenyl]carboxamide;

N-{2-[N-(5-ethynyl(2-pyridyl))carbamoyl]-4-chlorophenyl}[4-(iminopiperidinylmethyl)-2-fluorophenyl]carboxamide;

ethyl 1-{[4-(N-{4-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carbamoyl)-3-fluorophenyl]iminomethyl}piperidine-4-carboxylate;

{4-[(N-methylethylamino)iminomethyl]-2-fluorophenyl}-N-{4-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carboxamide;

{4-[(N-propylmethylamino)iminomethyl]-2-fluorophenyl}-N-4-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carboxamide;

{4-[Azetidinyiminomethyl]-2-fluorophenyl}-N-{4-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carboxamide;

{4-[(dimethylamino)iminomethyl]phenyl}-N-{6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carboxamide;

{4-[(dimethylamino)iminomethyl]phenyl}-N-{6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

N-{2-[N-(5-ethynyl(2-pyridyl))carbamoyl]-6-methoxyphenyl}[4-(iminopyrrolidinylmethyl)phenyl]carboxamide;

N-{2-[N-(5-ethynyl(2-pyridyl))carbamoyl]-6-methoxyphenyl}[4-(iminopiperidylmethyl)phenyl]carboxamide;

ethyl 1-{[4-(N-{6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carbamoyl)phenyl]iminomethyl}-piperidine-4-carboxylate;

{4-[(N-ethylmethylamino)iminomethyl]phenyl}-N-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

{4-[(N-methylpropylamino)iminomethyl]phenyl}-N-{6-methoxy-2-[n-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

{4-[Azetidinyliminomethyl]phenyl}-N-{6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

{4-[Azetidinylazetidinylidenemethy]phenyl}-N-{6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

[4-({[2-(dimethylamino)ethyl]methylamino}iminomethyl)phenyl]-N-{6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carboxamide;

{4-[(N-methyl-2-propynylamino)iminomethyl]phenyl}-N-{6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

{4-[(dimethylamino)iminomethyl]phenyl}-N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}[4-(1-methyl(2-imidazolin-2-yl))phenyl]-carboxamide;

N-{2-[N-(5-ethynyl(2-pyridyl))carbamoyl]-4-chloro-6-methoxyphenyl}[4-(iminopyrrolidinylmethyl)phenyl]carboxamide;

N-{2-[N-(5-ethynyl(2-pyridyl))carbamoyl]4-chloro-6-methoxyphenyl}[4-(iminopiperidylmethyl)phenyl]carboxamide;

ethyl 1-{[4-(N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carbamoyl)phenyl]iminomethyl}-piperidine-4-carboxylate;

1-{[4-(N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carbamoyl)phenyl]iminomethyl}-piperidine-4-carboxylic acid;

{4-[(N-ethylmethylamino)iminomethyl]phenyl}-N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

{4-[(N-methylpropylamino)iminomethyl]phenyl}-N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

4-[Azetidinylazetidinylidenemethy]phenyl)-N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

1-{[4-(N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carbamoyl)phenyl]iminomethyl}-piperidine-4-carboxamide;

{4-[(dimethylamino)iminomethyl]-2-fluorophenyl-N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}[4-(1-methyl(2-imidazolin-2-yl))-2-fluorophenyl]-carboxamide;

N-{2-[N-(5-ethynyl(2-pyridyl))carbamoyl]-4-chloro-6-methoxyphenyl}[4-(iminopyrrolidinylmethyl)-2-fluorophenyl]carboxamide;

N-{4-chloro-6-methoxy--2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}[4-(1-methyl(2-imidazolin-2-yl))2-fluorophenyl]-carboxamide;

ethyl 1-{[4-(N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carbamoyl)-2-fluorophenyl]iminomethyl}-piperidine-4-carboxylate;

1-{[4-(N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carbamoyl)-2-fluorophenyl]iminomethyl}-piperidine4-carboxylic acid;

{4-[azetidinyliminomethyl]-2-fluorophenyl}-N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

{4-[Azetidinylazetidinylidenemethy]-2-fluorophenyl}-N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

{4-[(N-ethylmethylamino)iminomethyl]-2-fluorophenyl}-N-(4chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

{4-[(N-methylpropylamino)iminomethyl]-2-fluorophenyl}-N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

[4-({[2-(dimethylamino)ethyl]methylamino}iminomethyl)-2-fluorophenyl]-N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carboxamide;

1-{[4-(N-{4-chloro-6methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]-2-fluorophenyl}carbamoyl)phenyl]iminomethyl}-piperidine-4-carboxamide;

{4-[(N-methyl(furanylmethyl)amino)iminomethyl]-2-fluorophenyl}-N-{4-chloro-6-methoxy-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}-carboxamide;

{4-[(dimethylamino)iminomethyl]phenyl}-N-{2-[N-(5-ethynyl(2pyridyl))carbamoyl]phenyl}-carboxamide;

N-{2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}[4-(1-methyl(2imidazolin-2-yl))phenyl]-carboxamide;

N-{2-[N-(5-ethynyl(2-pyridyl))carbamoyl]}[4-(iminopyrrolidinylmethyl)phenyl]carboxamide;

N-{2-[N-(5-ethynyl(2-pyridyl))carbamoyl]}[4-(iminopiperidylmethyl)phenyl]carboxamide;

ethyl 1-{[4-(N-{2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}carbamoyl)phenyl]iminomethyl}-piperidine-4-carboxylate;

N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}[4-(1-propyl(2-imidazolin-2-yl))phenyl]-carboxamide; and

N-{4-chloro-2-[N-(5-ethynyl(2-pyridyl))carbamoyl]phenyl}[4-(1-(2-hydroxy)ethyl(2-imidazolin-2-yl))phenyl]-carboxamide.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2005
From: ZHU, BING-YAN; ZHANG, PENGLIE; GOLDMAN, ERICK A.; JIA, ZHAOZONG JON; SONG, YONGHONG; WOOLFREY, JOHN; BAUER, SHAWN; HUANG, WENRONG; BAO, LIANG; WU, YANHONG; SU, TING; SCARBOROUGH, ROBERT M.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 015937/0322 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2002
From: DORNIER, JULES A., II; WILSON, JOHN M., SR.; WILSON, DEAN R.
To: WILCO MARSH BUGGIES AND DRAGLINES, INC.
Reel/Frame 013111/0750 →